Vusala Snyder
University of Kansas
10 Papers
2 Citations
Vusala Snyder is an academic researcher from University of Kansas. The author has contributed to research in topics: Medicine & Head and neck squamous-cell carcinoma. The author has an hindex of 2, co-authored 5 publications.
Chat about Author
Papers
Cancer Stem Cell Metabolism and Potential Therapeutic Targets
TL;DR: Key factors that impact CSC metabolic phenotype including heterogeneity of CSCs across different histologic tumor types, tissue-specific variations, tumor microenvironment, and CSC niche are reviewed including targeting key players of glycolytic and mitochondrial pathways.
188
Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds.
Vikalp Vishwakarma,Jacob New,Dhruv Kumar,Dhruv Kumar,Vusala Snyder,Levi Arnold,Emily Nissen,Qingting Hu,Nikki Cheng,David Miller,Ahia Rael Thomas,Yelizaveta Shnayder,Kiran Kakarala,Terance T. Tsue,Douglas A. Girod,Sufi M. Thomas +15 more
TL;DR: Combining nutraceuticals is examined, establishing a combination therapy that is more potent than any singular component, and delineate the mechanism of action to demonstrate GZ17-6.02 as a highly effective plant extract combination and pave the way for future clinical application in HNSCC.
Doublecortin-like kinase 1 is a therapeutic target in squamous cell carcinoma
David Standing,Levi Arnold,Prasad Dandawate,Brendan M. Ottemann,Vusala Snyder,Sivapriya Ponnurangam,Afreen Asif Ali Sayed,Dharmalingam Subramaniam,Pugazhendhi Srinivasan,Sonali Choudhury,Jacob New,Deep Kwatra,Prabhu Ramamoorthy,Badal C. Roy,Melissa Shadoin,Raed Al-Rajabi,Maura O'Neil,Sumedha Gunewardena,John Ashcraft,Shahid Umar,Scott Weir,Ossama Tawfik,Subhash Padhye,Shrikant Anant,Sufi M. Thomas +24 more
TL;DR: It is demonstrated that DiFiD [3,5-bis (2,4-difluorobenzylidene)-4-piperidone] binds to DCLK1 with high selectivity and significantly suppressed tumor growth of HNSCC xenografts and ASCC patient derived xenografteds, supporting that D CLK1 is critical for SCC growth.
8
Longitudinal Analysis of Caregiver Burden in Head and Neck Cancer.
Lauren D. Kudrick,Khalil Baddour,Richard Wu,Mark Fadel,Vusala Snyder,Aakriti Neopaney,Teresa Hagan Thomas,Lindsay M. Sabik,Marci Lee Nilsen,Jonas T. Johnson,Robert L. Ferris,Seyed Mehdi Nouraie,Leila J. Mady +12 more
TL;DR: A longitudinal prospective cohort study as discussed by the authors evaluated the prevalence of and identified risk factors for caregivers in head and neck cancer (HNC) survivorship, and highlighted patient- and caregiver-specific factors that are associated with increased caregiver burden.
5
Abstract 5540: Antitumor efficacy of synthetic formulations of active components in Arum palaestinum extracts in head and neck squamous cell carcinoma
Vikalp Vishwakarma,Kyle Crooker,Vusala Snyder,Jeffrey Straub,Caitlin Cole,Annie Lee,Lisa Stehno Bittel,Sufi M. Thomas +7 more
TL;DR: The preliminary data demonstrates that synthetic formulations of Arum palaestinum extract have antitumor efficacy in several tumor types including HNSCC, lung and ovarian cancer cells.
1